​

Vericel (VCEL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VCEL Stock Forecast

Vericel (VCEL) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $41.00, with a high of $41.00 and a low of $41.00. This represents a 12.42% increase from the last price of $36.47.

$35 $40 $45 $50 $55 $60 High: $41 Avg: $41 Low: $41 Last Closed Price: $36.47

VCEL Stock Rating

Vericel stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (64.29%), 5 Hold (35.71%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 5 9 Strong Sell Sell Hold Buy Strong Buy

VCEL Price Target Upside V Benchmarks

TypeNameUpside
StockVericel12.42%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$41.00$41.00$54.00
Last Closing Price$36.47$36.47$36.47
Upside/Downside12.42%12.42%48.07%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25161--8
Sep, 2517---8
Aug, 2517---8
Jul, 2517---8
Jun, 2517---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2025Truist Financial$41.00$34.5018.84%12.42%
Dec 18, 2024Richard NewitterTruist Financial$67.00$56.2519.11%83.71%
Aug 26, 2024Ryan ZimmermanBTIG$55.00$50.059.89%50.81%
Aug 02, 2024Swayampakula RamakanthH.C. Wainwright$60.00$47.5226.26%64.52%
Jul 16, 2024Richard NewitterTruist Financial$57.00$52.109.40%56.29%
Jul 05, 2024Ryan ZimmermanBTIG$56.00$46.6819.97%53.55%
Jan 25, 2024Samuel BrodovskyTruist Financial$51.00$42.6019.72%39.84%
Jan 03, 2023H.C. Wainwright$37.00$25.1347.23%1.45%
Dec 20, 2022Truist Financial$25.00$23.207.76%-31.45%
Jul 18, 2022BTIG$34.00$28.2020.57%-6.77%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 26, 2024BTIGBuyBuyhold
Aug 16, 2024Cowen & Co.BuyBuyhold
Aug 02, 2024H.C. WainwrightBuyBuyhold
Jul 05, 2024BTIGBuyBuyhold
Jun 25, 2024Cowen & Co.BuyBuyhold
Jun 20, 2024Cowen & Co.OutperformBuyinitialise
May 09, 2024Truist FinancialBuyBuyhold
May 09, 2024H.C. WainwrightBuyBuyhold
Apr 15, 2024BTIGBuyBuyhold
Mar 26, 2024Truist FinancialBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.06$-0.16$-0.35$-0.07$0.21----
Avg Forecast$0.01$-0.11$-0.44$-0.16$0.13$0.45$0.85$1.30$1.76
High Forecast$0.01$-0.11$-0.43$-0.13$0.17$0.63$1.09$1.58$1.78
Low Forecast$0.01$-0.12$-0.46$-0.19$0.08$0.36$0.66$1.04$1.75
Surprise %500.00%45.45%-20.45%-56.25%61.54%----

Revenue Forecast

$100M $200M $300M $400M $500M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$124.18M$156.18M$164.37M$197.52M$237.22M----
Avg Forecast$123.94M$157.58M$164.57M$196.46M$238.56M$289.99M$363.79M$466.74M$569.36M
High Forecast$127.05M$161.53M$170.43M$198.33M$239.38M$290.61M$363.94M$471.17M$574.76M
Low Forecast$121.40M$154.34M$161.84M$196.45M$237.08M$289.37M$363.65M$464.18M$566.23M
Surprise %0.19%-0.88%-0.12%0.54%-0.56%----

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.86M$-7.47M$-16.71M$-3.18M$10.36M----
Avg Forecast$15.72M$-6.80M$-9.46M$-3.18M$5.90M$23.47M$45.28M$70.96M$83.76M
High Forecast$24.06M$-2.98M$-4.86M$-1.71M$8.21M$30.07M$51.98M$75.19M$84.79M
Low Forecast$7.39M$-10.62M$-14.06M$-4.66M$3.59M$17.25M$31.47M$49.49M$83.16M
Surprise %-81.78%9.84%76.59%-75.51%----

VCEL Forecast FAQ

Is Vericel stock a buy?

Vericel stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vericel is a favorable investment for most analysts.

What is Vericel's price target?

Vericel's price target, set by 14 Wall Street analysts, averages $41 over the next 12 months. The price target range spans from $41 at the low end to $41 at the high end, suggesting a potential 12.42% change from the previous closing price of $36.47.

How does Vericel stock forecast compare to its benchmarks?

Vericel's stock forecast shows a 12.42% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Vericel over the past three months?

  • October 2025: 12.50% Strong Buy, 75.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Vericel’s EPS forecast?

Vericel's average annual EPS forecast for its fiscal year ending in December 2025 is $0.45, marking a 114.29% increase from the reported $0.21 in 2024. Estimates for the following years are $0.85 in 2026, $1.3 in 2027, and $1.76 in 2028.

What is Vericel’s revenue forecast?

Vericel's average annual revenue forecast for its fiscal year ending in December 2025 is $289.99M, reflecting a 22.24% increase from the reported $237.22M in 2024. The forecast for 2026 is $363.79M, followed by $466.74M for 2027, and $569.36M for 2028.

What is Vericel’s net income forecast?

Vericel's net income forecast for the fiscal year ending in December 2025 stands at $23.47M, representing an 126.47% increase from the reported $10.36M in 2024. Projections indicate $45.28M in 2026, $70.96M in 2027, and $83.76M in 2028.